R
ENDORSED BY INDUSTRY LEADERS
Dozens of companies and organizations have joined together in the effort to regulate CBD now.
THE FDA NEEDS A LEGISLATIVE SOLUTION FOR ITS REGULATORY PROBLEM.
WHAT'S THE PROBLEM?
When Congress passed the 2018 Farm Bill, it explicitly legalized the sale of hemp and its derivatives such as cannabidiol or CBD. Farmers across the nation relied on this government action, and invested considerable time and resources to plant, grow, and market commercial hemp crops, and particularly for the market for which there is immediate processing infrastructure and consumer demand: hemp-derived CBD and cannabinoids.
Unfortunately, regulatory uncertainty regarding the legality of hemp-derived CBD has started to dismantle the up-and-coming market, limiting demand from the manufacturing sector, and resulting in a sharp decline in hemp prices and economic hardship for hemp farmers. While FDA has recognized the significant public interest in CBD, and scientific studies have consistently demonstrated its strong safety profile, the agency has not yet established a legal pathway for its sale, claiming the law puts the agency in a "stalemate position."
At the same time, a multitude of products continue to be sold under the guise of the hemp name, some of which raise significant quality, safety, intoxication and other consumer protection concerns, since FDA is not, for the most part, ensuring these products' compliance with most federal regulations.
​
WHAT'S AT STAKE?
Failing to establish a regulatory pathway for legalizing hemp-derived CBD will continue to reduce economic opportunity for U.S. hemp farmers and deny consumers access to safe, quality products. Scott Melville, President of the Consumer Healthcare Products Association (CHPA), says “the ongoing lack of regulatory clarity is keeping responsible consumer companies on the sidelines, while public safety is being threatened by unscrupulous hemp and CBD product manufacturers.”
​
The lack of regulatory clarity has led to bankruptcies of CBD processing facilities, leaving farmers left with raw hemp material they are unable to sell. Blackmarket CBD brands are selling products made without proper protocols or testing. The hemp industry in its entirety is at stake! From the success of hemp producers to the safety of hemp consumers, the market will not make it if Congress and the FDA do not move quickly. This is why we need your help!
​
​
​
​
REGULATION MEANS CONSUMER SAFETY AND ECONOMIC STIMULUS
ONE SMALL ACTION CAN MAKE A HUGE DIFFERENCE
HOW YOU CAN HELP!
Believe it or not, your elected officials DO listen to their constituents.... when they speak up! That's why we need YOU to take action by using this online portal to send a quick message to your Congress members asking them to support the regulation of hemp-derived CBD.
​
There are other ways you can help! Share regulateCBDnow.com with your friends and followers by posting on social media or linking to an eblast encouraging them to use the online portal to take action, too!
Check out our resources for educational materials on regulating hemp-derived CBD, and use them to get the word out about this important issue! Don't forget to use the hashtags #StopTheStalemate and #RegulateCBDnow with your social posts to amplify our voice!
​
TAKE ACTION
TODAY
Please select each button below and fill out the forms to urge your members of Congress to co-sponsor legislation that would regulate CBD now. It’s as simple as entering your email address and zip code, and then personalizing the message that we have prepared for your review.
​
​
